Introduction The aim of this work was to identify new renin target genes in left ventricular hypertrophy during hypertension.
Materials and methods We compared left ventricle gene expression from four transgenic TGR(mRen2)27 (TG+/-) rats and four non-transgenic littermates (TG-/-) using cDNA macroarray. Hybridisation signals were quantified with a phosphorimager, and normalised to an external scale. Data analysis was performed with Statistical Analysis for Microarrays (SAM 1.21) software. The mRNA levels of candidate genes were determined by semi-quantitative RT-PCR in three different hypertensive rats: TG+/-, spontaneously hypertensive (SHR) and genetically Lyon hypertensive (LH) rats, compared to their respective controls (TG-/-, Wistar-Kyoto, Lyon low blood pressure rats).
Results Out of 1,200 genes present on the macroarray, 233 were reliably measured and only three were overexpressed (Biglycan, β1-adenosine monophosphate-activated protein kinase [AMPK] and amyloid precursor like protein 2 [APLP2]) and 19 were underexpressed in the left ventricle of TG+/compared with TG-/-. APLP2 is a member of the amyloid precursor protein (APP) family. APLP2 and APP mRNA levels were increased in TGR(mRen2)27 but significantly decreased in LH rats, while only APP was increased in SHR rats.
Conclusions We report new genes associated with renin-dependent left ventricular hypertrophy. Moreover, this work shows for the first time that the APP family gene expression could be altered in response to high renin activity and this effect is independent of cardiac remodelling and hypertension.
Ruwhof C., van der Laarse A.Mechanical stress-induced cardiac hypertrophy: mechanisms and signal transduction pathways. Cardiovasc Res2000 ;47:23-37.
4.
Swynghedauw B.Molecular mechanisms of myocardial remodeling . Physiol Rev1999;79:215-62.
5.
Neyses L., Pelzer T.The biological cascade leading to cardiac hypertrophy. Eur Heart J1995;16:8-11.
6.
Chien KR, Knowlton KU, Zhu H., Chien S.Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response. FASEB J1991;5:3037-46.
7.
Izumo S., Nadal-Ginard B., Mahdavi V.Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc NatlAcad Sci USA1988;85:339-43.
8.
Baker KM, Booz GW, Dostal DECardiac actions of angiotensin II: Role of an intracardiac renin-angiotensin system. Annu Rev Physiol1992;54:227-41.
9.
Goodfriend TL , Elliott ME, Catt KJAngiotensin receptors and their antagonists . N Engl JMed1996;334:1649-54.
10.
Schlaich MP , Schmieder RELeft ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents. Am J Hypertens1998;11:1394-404.
11.
Roman MJ,Alderman MH, Pickering TG et al. Differential effects of angiotensin converting enzyme inhibition and diuretic therapy on reductions in ambulatory blood pressure, left ventricular mass, and vascular hypertrophy. Am J Hypertens1998;11:387-96.
12.
Mullins JJ, Peters J., Ganten D.Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene . Nature1990;344:541-4.
13.
Lee MA, Bohm M., Kim S. et al. Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat.Hypertension1995;25:570-80.
14.
Campbell DJ, Rong P., Kladis A., Rees B., Ganten D., Skinner SLAngiotensin and bradykinin peptides in the TGR(mRen-2)27 rat. Hypertension1995;25:1014-20.
15.
Ohta K., Kim S., Wanibuchi H., Ganten D., Iwao H.Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR (mRen2)27 transgenic rats. Circulation1996;94:785-91.
16.
Sandbrink R. , Masters CL, Beyreuther K.Similar alternative splicing of a non-homologous domain in beta A4-amyloid protein precursor-like proteins. J Biol Chem1994;269:14227-34.
17.
BayerTA,Cappai R. , Masters CL, Beyreuther K., Multhaup G.It all sticks together: the APP-related family of proteins and Alzheimer's disease. Mol Psychiatry1999;4:524-8.
18.
Tusher VG, Tibshirani R., Chu G.Significance analysis of microarrays applied to the ionizing radiation response . Proc Natl Acad Sci USA2001;98:5116-21.
19.
Schonherr E. , Witsch-Prehm P., Harrach B., Robenek H., Rauterberg J., Kresse H.Interaction of biglycan with type I collagen . J Biol Chem1995;270:2776-83.
20.
HildebrandA,Romaris M., Rasmussen LM et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J1994;302:527-34.
21.
Shihab FS, Andoh TF, Tanner AM, Bennett WMSodium depletion enhances fibrosis and the expression of TGF-beta1 and matrix proteins in experimental chronic cyclosporine nephropathy. Am J Kidney Dis1997;30:71-81.
22.
AyadaY.,Kusachi S., Murakami T. et al. Increased expression of biglycan mRNA in pressure-overloaded rat heart. Clin Exp Hypertens2001;23:633-43.
23.
Ahmed MS, Oie E., Vinge LE et al. Induction of myocardial biglycan in heart failure in rats--an extracellular matrix component targeted by AT(1) receptor antagonism. Cardiovasc Res2003;60:557-68.
24.
Hayashi T., Hirshman MF, Kurth EJ, Winder WW, Goodyear LJEvidence for 5' AMP-activated protein kinase mediation of the effect of muscle contraction on glucose transport. Diabetes1998;47:1369-73.
25.
Kudo N., Gillespie JG, Kung L. et al. Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochim Biophys Acta1996 ;1301:67-75.
26.
Tian R., Musi N., D'Agostino J., Hirshman MF, Goodyear LJIncreased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation2001;104:1664-9.
27.
Sambandam N. , Lopaschuk GDAMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Prog Lipid Res2003;42:238-56.
28.
Coven DL, Hu X., Cong L. et al. Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise. Am J Physiol Endocrinol Metab2003;285:629-36.
29.
Daniel T., Carling D.Functionalanalysis of mutations in the gamma 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome .JBiol Chem2002;277:51017-24.
30.
Ono K., Iwanaga Y., Mannami T. et al. Epidemiological evidence of an association between SLC6A2 gene polymorphism and hypertension. Hypertens Res2003;26:685-9.
31.
MohriT. ,Emoto N. , Nonaka H. et al.Alterations of circadian expressions of clock genes in Dahl salt-sensitive rats fed a high-salt diet . Hypertension2003;42:189-94.
32.
Young ME, Razeghi P., Taegtmeyer H.Clock genes in the heart: characterization and attenuation with hypertrophy . Circ Res2001;88:1142-50.
33.
Pan L., Glenn ST, Jones CA, Gronostajski RM, Gross KWRegulation of renin enhancer activity by nuclear factor I and Sp1/Sp3 . Biochim Biophys Acta2003;1625:280-90.
34.
Rossjohn J. , Cappai R., Feil SC et al. Crystal structure of the N-terminal, growth factor-like domain of Alzheimer amyloid precursor protein. Nat Struct Biol1999;6:327-31.
35.
Von Koch CS , Zheng H., Chen H. et al. Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice. Neurobiol Aging1997;18:661-9.
36.
Heber S., Herms J., Gajic V. et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci2000;20:7951-63.
37.
Dempsey AA, Pabalan N., Tang HC, Liew CCOrganization of human cardiovascular-expressed genes on chromosomes 21 and 22. J Mol Cell Cardiol2001;33:587-91.
38.
Lis CG, Gaviria M.Vascular dementia, hypertension, and the brain. Neurol Res1997;19:471-80.
39.
Skoog I.The relationship between blood pressure and dementia: a review. Biomed Pharmacother1997;51:367-75.
40.
Farrer LA, Sherbatich T., Keryanov SA et al. Association between angiotensin-converting enzyme and Alzheimer disease. Arch Neurol2000;57:210-14.
41.
Crawford F. , Abdullah L., Schinka J. et al. Gender-specific association of the angiotensin converting enzyme gene with Alzheimer's disease . Neurosci Lett2000;280:215-19.
42.
Monastero R. , Caldarella R., Mannino M. et al. Lack of association between angiotensin converting enzyme polymorphism and sporadic Alzheimer's disease. Neurosci Lett2002; P335:147-9.
43.
Pachori AS, Numan MT, Ferrario CM, Diz DM, Raizada MK, Katovich MJBlood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy. Hypertension2002;39:969-75.
44.
Sano H., Okamoto H., Kitabatake A., Iizuka K., Murakami T., Kawaguchi H.Increased mRNA expression of cardiac renin-angiotensin system and collagen synthesis in spontaneously hypertensive rats.Mol Cell Biochem1998;178:51-8.
45.
Jurkovicova D., Dobesova Z., Kunes J., Krizanova O.Different expression of renin-angiotensin system components in hearts of normotensive and hypertensive rats. Physiol Res2001;50: 35-42.
46.
Sassard J., Lo M., Liu KLLyon genetically hypertensive rats: an animal model of `low renin hypertension` . Acta Pharmacol Sin2003;24:1-6.
